Dosimetry assessments from biodistribution data in PSMA-high tumor-bearing mice were performed to estimate the absorbed radiation dose in human organs for starting dose selection of 212Pb-ADVC001 in first-in-human trials. The gene discussed is FOLH1; the disease is neoplasm.